TABLE III.
Response | Cabozantinib [n (%)] | Nivolumab [n (%)] |
---|---|---|
Complete response | 1 (3) | 2 (1) |
Partial response | 7 (18) | 28 (20) |
Stable disease | 23 (58) | 48 (34) |
Progressive disease | 9 (23) | 62 (44) |
Overall response rate | 8 (20) | 30 (21) |
p=0.85 |
Response | Cabozantinib [n (%)] | Nivolumab [n (%)] |
---|---|---|
Complete response | 1 (3) | 2 (1) |
Partial response | 7 (18) | 28 (20) |
Stable disease | 23 (58) | 48 (34) |
Progressive disease | 9 (23) | 62 (44) |
Overall response rate | 8 (20) | 30 (21) |
p=0.85 |